MWC researchers discover new path to potential anti-cancer, antibiotic drugs
23 September 2020
A team of MWC investigators has gained some key new insights into the molecular assembly of certain anti-cancer and antibiotic molecules - paving the way for the design of more effective drugs to treat cancer or antibiotic-resistant superbugs.
MWC melanoma research makes high impact
14 August 2020
Novel research by MWC investigators studying the effects of melanoma tumour in human lymph nodes has been selected for the front cover of Cancer Immunology Research journal's August 2020 issue.
Kiwi scientists develop powerful melanoma research tool
16 July 2020
A nationwide group of researchers from the Maurice Wilkins Centre has recently reported a detailed characterisation of one of the largest melanoma cell line panels ever developed that makes this a resource for research of international importance.
New imaging improves our understanding of the immune system
4 March 2020
Maurice Wilkins Centre researchers have used novel imaging technology to reveal the structure and inner workings of entire lymph nodes, core components of the body’s immune system.
Lung cancer drug poised for global approval, says MWC investigator
11 December 2017
Dacomitinib, an irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor developed in collaboration with Pfizer by researchers led by MWC Associate Investigator Dr. Jeff Smaill, has shown significant efficacy in the treatment of patients with non-small-...
Dr Aniruddha Chatterjee awarded Rutherford Discovery Fellowship
13 October 2017
MWC Affiliate Investigator Dr Aniruddha Chatterjee of the University of Otago is one of only ten recipients across the country to be awarded a 2017 Rutherford Discovery Fellowship.
Newly funded research highlights MWC collaborations
7 November 2016
Professor Gavin Painter from Victoria University’s Ferrier Research Institute has been awarded funding in the Ministry of Business, Innovation and Employment’s 2016 Endeavour Fund science investment round.
Prestigious award for cancer researcher
11 September 2016
Cancer biologist Professor Antony Braithwaite has received the New Zealand Association of Scientists (NZAS) Shorland Medal in recognition of his work on the tumour suppressor protein p53 and other cancer associated genes.